158318-63-9

158318-63-9 structure

Name: Bectumomab
Chemical Name: Bectumomab
CAS Number: 158318-63-9
Molecular Formula:
Molecular Weight:
Catalog: Research Areas Cancer
Create Date: 2018-12-05 05:14:49
Modify Date: 2024-01-03 11:25:05
Bectumomab (IMMU-LL 2) is an humanized IgG2a mAb against human CD22 (antigen). Bectumomab is also an anti-lymphoma antibody fragment. Bectumomab can be used for imaging in combination with technetium 99 (Tc99m LL2 Fab). Moreover, Bectumomab examines in the staging of recurrent or newly diagnosed non-Hodgkin's lymphoma (NHL) and to assess targeting before radioimmunotherapy (RIT)[1].

Name	Bectumomab

Description	Bectumomab (IMMU-LL 2) is an humanized IgG2a mAb against human CD22 (antigen). Bectumomab is also an anti-lymphoma antibody fragment. Bectumomab can be used for imaging in combination with technetium 99 (Tc99m LL2 Fab). Moreover, Bectumomab examines in the staging of recurrent or newly diagnosed non-Hodgkin's lymphoma (NHL) and to assess targeting before radioimmunotherapy (RIT)[1].
Related Catalog	Research Areas >> Cancer Signaling Pathways >> Others >> Others
Target	CD22[1]
In Vitro	Bectumomab 可与小鼠单克隆免疫球蛋白 LL-2 轻链二硫化形成二聚体[1]。
References	[1]. Lamonica D, et al. Radioimmunoscintigraphy (RIS) with bectumomab (Tc99m labeled IMMU-LL2, Lymphoscan) in the assessment of recurrent non-Hodgkin's lymphoma (NHL). Cancer Biother Radiopharm. 2002 Dec;17(6):689-97.

No Any Chemical & Physical Properties